Anna Blach
Overview
Explore the profile of Anna Blach including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
90
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Blach A, Surma S, Chrabanski O, Balys M, Haberka M
Kardiol Pol
. 2025 Jan;
PMID: 39878645
No abstract available.
2.
Sajdok M, Kawa M, Miszczyk M, Blach A, Chrabanski O, Soral T, et al.
Kardiol Pol
. 2024 Jan;
81(12):1290-1292.
PMID: 38189510
No abstract available.
3.
Kostorz-Nosal S, Jastrzebski D, Blach A, Skoczynski S
Respir Physiol Neurobiol
. 2023 Aug;
316:104135.
PMID: 37536553
Oscillometry has been around for almost 70 years, but there are still many unknowns. The test is performed during tidal breathing and is therefore free from patient-dependent factors that could...
4.
Blach A, Kwiecinski J
Diagnostics (Basel)
. 2023 May;
13(10).
PMID: 37238275
Cardiovascular disease remains the leading cause of morbidity and mortality worldwide. For developing new therapies, a better understanding of the underlying pathology is required. Historically, such insights have been primarily...
5.
Blach A, Pangle A, Azhar G, Wei J
Gerontol Geriatr Med
. 2022 May;
8:23337214221098901.
PMID: 35591952
Healthcare is currently struggling to provide access and coverage for an increasingly diverse aging population who frequently have multiple co-morbid conditions complicating their care and medical management. This retrospective study...
6.
Kurzelowski R, Baranski K, Caluori G, Szot W, Grabowski K, Michalewska-Wludarczyk A, et al.
Postepy Kardiol Interwencyjnej
. 2021 Nov;
17(3):281-289.
PMID: 34819964
Introduction: Cell therapy has the potential to improve symptoms and clinical outcomes in refractory angina (RFA). Further analyses are needed to evaluate factors influencing its therapeutic effectiveness. Aim: Assessment of...
7.
Wynimko M, Walicka M, Sanchak Y, Gozdowski D, Blach A, Wiecek A, et al.
J Clin Med
. 2020 Jun;
9(6).
PMID: 32585986
Chronic periodontitis (CP) is associated with cardiovascular disease and mortality in different populations. The aim of this study was to examine an association of CP with hard endpoints in patients...
8.
Jadczyk T, Ciosek J, Michalewska-Wludarczyk A, Szot W, Parma Z, Ochala B, et al.
Cardiol J
. 2018 Sep;
25(4):521-529.
PMID: 30211929
Background: The REGENT-VSEL trial demonstrated a neutral effect of transendocardial injection of autologous bone marrow (BM)-derived CD133+ in regard to myocardial ischemia. The current sub-analysis of the REGENT VSEL trial...
9.
Wojakowski W, Jadczyk T, Michalewska-Wludarczyk A, Parma Z, Markiewicz M, Rychlik W, et al.
Circ Res
. 2016 Dec;
120(4):670-680.
PMID: 27903568
Rationale: New therapies for refractory angina are needed. Objective: Assessment of transendocardial delivery of bone marrow CD133 cells in patients with refractory angina. Methods And Results: Randomized, double-blinded, placebo-controlled trial...
10.
Franek E, Januszkiewicz-Caulier J, Blach A, Napora M, Jedynasty K, Budlewski T, et al.
Kardiol Pol
. 2012 Jan;
70(1):7-13.
PMID: 22267416
Background: Periodontal disease is an inflammatory process which results in increased cardiovascular risk in patients with type 2 diabetes mellitus (DM2). It is not clear, however, whether periodontal inflammation may...